o,p'-DDD (mitotane) treatment of canine pituitary-dependent hyperadrenocorticism.
D000324:Adrenocorticotropic Hormone; D000818:Animals; D003348:Cortisone / Q000627:therapeutic use; D003480:Cushing Syndrome / Q000150:complications / Q000188:drug therapy / Q000662:veterinary*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000662:veterinary; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005938:Glucocorticoids / Q000627:therapeutic use; D006854:Hydrocortisone / Q000097:blood; D008939:Mitotane / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use
D005938:Glucocorticoids; D008939:Mitotane; D000324:Adrenocorticotropic Hormone; D003348:Cortisone; D011241:Prednisone; D006854:Hydrocortisone